Literature DB >> 29036313

High Interspecimen Variability in Nucleic Acid Extraction Efficiency Necessitates the Use of Spike-In Control for Accurate qPCR-based Measurement of Plasma Cell-Free DNA Levels.

Grant C O'Connell1,2, Paul D Chantler3,4, Taura L Barr5.   

Abstract

OBJECTIVE: To assess the interspecimen variability associated with plasma DNA extraction in order to provide insight regarding the necessity to use an exogenous spike-in control when measuring cell-free DNA (cfDNA) levels using quantitative polymerase chain reaction (qPCR).
METHODS: Plasma specimens were obtained from 8 healthy individuals, 20 patients with cardiovascular disease risk factors, and 54 patients diagnosed with acute stroke. Specimens were spiked with an exogenous oligonucleotide fragment, and total DNA was extracted via automated solid phase anion exchange. We determined recovery of the exogenous fragment via qPCR and used this information to calculate DNA extraction efficiency.
RESULTS: Plasma DNA extraction efficiencies varied dramatically between specimens, ranging from 22.9% to 88.1%, with a coefficient of variance of 28.9%. No significant differences in DNA extraction efficiencies were observed between patient populations.
CONCLUSIONS: We strongly recommend the use of an exogenous spike-in control to account for variance in plasma DNA extraction efficiency when assessing cell free DNA (cfDNA) levels by qPCR in future biomarker investigations. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  CNAPS; blood; housekeeping; liquid biopsy; methods; normalization; polymerase chain reaction; reference; serum; standard

Mesh:

Substances:

Year:  2017        PMID: 29036313      PMCID: PMC5907903          DOI: 10.1093/labmed/lmx043

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  26 in total

1.  The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences.

Authors:  P Stothard
Journal:  Biotechniques       Date:  2000-06       Impact factor: 1.993

2.  Differential bone marrow aspirate DNA yields from commercial extraction kits.

Authors:  R Aplenc; E Orudjev; J Swoyer; B Manke; T Rebbeck
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

3.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

4.  Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays.

Authors:  Gabriella Sozzi; Luca Roz; Davide Conte; Luigi Mariani; Francesca Andriani; Paolo Verderio; Ugo Pastorino
Journal:  J Natl Cancer Inst       Date:  2005-12-21       Impact factor: 13.506

5.  Extraction of cellular DNA from crude cell lysate with glass.

Authors:  J D Thompson; K K Cuddy; D S Haines; D Gillepsie
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

6.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

Authors:  Evan M Kroh; Rachael K Parkin; Patrick S Mitchell; Muneesh Tewari
Journal:  Methods       Date:  2010-02-08       Impact factor: 3.608

7.  Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA.

Authors:  Tobias M Gorges; Johanna Schiller; Arndt Schmitz; Daniel Schuetzmann; Christoph Schatz; Thomas M Zollner; Thomas Krahn; Oliver von Ahsen
Journal:  Biomarkers       Date:  2012-05-23       Impact factor: 2.658

Review 8.  Circulating nucleic acids (CNAs) and cancer--a survey.

Authors:  M Fleischhacker; B Schmidt
Journal:  Biochim Biophys Acta       Date:  2006-10-07

Review 9.  Circulating nucleic acids in plasma/serum.

Authors:  Jason C H Tsang; Y M Dennis Lo
Journal:  Pathology       Date:  2007-04       Impact factor: 5.306

10.  Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA.

Authors:  Patricia Valda Toro; Bracha Erlanger; Julia A Beaver; Rory L Cochran; Dustin A VanDenBerg; Elizabeth Yakim; Karen Cravero; David Chu; Daniel J Zabransky; Hong Yuen Wong; Sarah Croessmann; Heather Parsons; Paula J Hurley; Josh Lauring; Ben Ho Park
Journal:  Clin Biochem       Date:  2015-07-31       Impact factor: 3.281

View more
  1 in total

1.  Inhibition monitoring in veterinary molecular testing.

Authors:  Lifang Yan; Kathy L Toohey-Kurth; Beate M Crossley; Jianfa Bai; Amy L Glaser; Rebecca L Tallmadge; Laura B Goodman
Journal:  J Vet Diagn Invest       Date:  2019-11-18       Impact factor: 1.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.